A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical Cancer

Clinical trial NCT07168200 · RECRUITING

Trial details

NCT number: NCT07168200
Sponsor: Shanghai Shengdi Pharmaceutical Co., Ltd
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Advanced Cervical Cancer

Start date: 2025-10-17
Primary completion: 2028-04-01
Enrollment: 720

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.